Medifast, Inc. Announces Quarterly Dividend
Medifast, Inc. (NYSE: MED) declared a $1.64 quarterly cash dividend for stockholders, payable on August 8, 2022, to those on record by June 28, 2022. The company is recognized as a leader in the weight management industry, impacting over 2 million lives with its OPTAVIA® program. The decision to pay future dividends will depend on the Board's discretion, considering relevant factors. Medifast aims to maintain quarterly dividend payments, signaling confidence in its financial stability and commitment to its shareholders.
- Quarterly cash dividend of $1.64 per share boosts shareholder income.
- Medifast has impacted over 2 million lives, demonstrating strong community engagement.
- None.
BALTIMORE, June 16, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that its Board of Directors has declared a
Medifast expects to maintain a program of paying dividends on a quarterly basis. However, the declaration of dividends in the future is subject to the discretion of the company's Board of Directors, who will evaluate the company's dividend program from time to time based on factors that it deems relevant.
Medifast (NYSE: MED) is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of independent OPTAVIA Coaches and a Community to help Customers achieve Lifelong Transformation, One Healthy Habit at a Time®. As the publicly traded market leader by revenue in the U.S.
Please Note: This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend," "anticipate," "expect" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. These statements are based on the current expectations of the management of Medifast and are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others: constraints, volatility or disruptions in the capital markets or other factors affecting the amount and timing of share repurchases under Medifast's accelerated share repurchase program; risks associated with Medifast's direct-to-consumer business model; the impact of rapid growth on Medifast's systems; disruptions in Medifast's supply chain; Medifast's inability to continue to develop new products; effectiveness of Medifast's advertising and marketing programs, including use of social media by independent OPTAVIA Coaches; Medifast's inability to maintain and grow the network of independent OPTAVIA Coaches; the departure of one or more key personnel; Medifast's inability to protect against online security risks, to protect its brand, or to protect against product liability claims; Medifast's planned growth into domestic and international markets; adverse publicity associated with Medifast's products; Medifast's inability to continue declaring dividends; fluctuations of Medifast's common stock market price; the impact of the COVID-19 pandemic on Medifast's results and the severity, length and ultimate impact of the COVID-19 pandemic on people and economies; increases in competition, litigation, natural disasters, acts of war, other geopolitical events, climate change, shareholder activism, regulatory changes, inflation, labor shortages, supply chain issues and the resulting impact on market conditions and consumer spending; and the impact of changes in internal control over financial reporting. Although Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its Annual Report on Form 10-K for the fiscal year ended December 31, 2021, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
MED-F
View original content to download multimedia:https://www.prnewswire.com/news-releases/medifast-inc-announces-quarterly-dividend-301569942.html
SOURCE Medifast, Inc.
FAQ
What is the dividend amount declared by Medifast in June 2022?
When is the dividend payable for Medifast?
What is the record date for Medifast's dividend?
Will Medifast continue to pay dividends in the future?
